Audit and Risk Committee
The Audit and Risk Committee has primary responsibility for monitoring the quality of internal controls, ensuring that the financial performance of the Company is properly measured and reported on and reviewing reports from the Company’s auditors relating to the Company’s accounting and internal controls, in all cases having due regard to the interests of Ergomed’s shareholders.
The Audit and Risk Committee is also responsible for ensuring that the Company is complying with the AIM rules and its corporate governance obligations and for assessing the Company’s corporate governance practices.
The Audit and Risk Committee meets at least twice a year. Michael Spiteri and Dr Llew Keltner are the members of the Audit and Risk Committee.
The Remuneration Committee has Michael Spiteri as Chair, and reviews the performance of the executive directors and determines their terms and conditions of service, including their remuneration and the grant of options, having due regard to the interests of shareholders.
The Remuneration Committee meets at least twice a year. Mark Enyedy is the other member of the Remuneration Committee.
The Nomination Committee has Dr. Miroslav Reljanovic as Chair, and identifies and nominates for the approval of the Board, candidates to fill board vacancies as and when they arise.
The Nomination Committee meets at least twice a year. Michael Spiteri is the other member of the Nomination Committee.